 | • レポートコード：MRC2102QY7520 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の過敏性腸症候群（IBS）市場について種類別（IBS-D薬、IBS-C薬、その他）、用途別（女性、男性）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・過敏性腸症候群（IBS）市場の概要 ・世界の主要地域別過敏性腸症候群（IBS）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の過敏性腸症候群（IBS）市場規模2015-2026：種類別（IBS-D薬、IBS-C薬、その他） ・世界の過敏性腸症候群（IBS）市場規模2015-2026：用途別（女性、男性） ・過敏性腸症候群（IBS）の米国市場規模2015-2020 ・過敏性腸症候群（IBS）のヨーロッパ市場規模2015-2020 ・過敏性腸症候群（IBS）の中国市場規模2015-2020 ・過敏性腸症候群（IBS）の日本市場規模2015-2020 ・過敏性腸症候群（IBS）の東南アジア市場規模2015-2020 ・過敏性腸症候群（IBS）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・過敏性腸症候群（IBS）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・過敏性腸症候群（IBS）の市場動向・機会・課題 ・調査の結論 |
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
Market Analysis and Insights: Global Irritable Bowel Syndrome (IBS) Market
The global Irritable Bowel Syndrome (IBS) market size is projected to reach US$ 5179.7 million by 2026, from US$ 3345 million in 2020, at a CAGR of 7.6% during 2021-2026.
Global Irritable Bowel Syndrome (IBS) Scope and Market Size
The global Irritable Bowel Syndrome (IBS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome (IBS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Irritable Bowel Syndrome (IBS) market is segmented into
IBS-D Drug
IBS-C Drug
Other
Segment by Application, the Irritable Bowel Syndrome (IBS) market is segmented into
Women
Men
The Irritable Bowel Syndrome (IBS) market is analysed and market size information is provided by regions (countries). Segment by Application, the Irritable Bowel Syndrome (IBS) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Irritable Bowel Syndrome (IBS) Market Share Analysis
Irritable Bowel Syndrome (IBS) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Irritable Bowel Syndrome (IBS) business, the date to enter into the Irritable Bowel Syndrome (IBS) market, Irritable Bowel Syndrome (IBS) product introduction, recent developments, etc.
The major vendors covered:
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals
1 Irritable Bowel Syndrome (IBS) Market Overview
1.1 Irritable Bowel Syndrome (IBS) Product Scope
1.2 Irritable Bowel Syndrome (IBS) Segment by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Sales by Type (2020-2026)
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Other
1.3 Irritable Bowel Syndrome (IBS) Segment by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Sales Comparison by Application (2020-2026)
1.3.2 Women
1.3.3 Men
1.4 Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Irritable Bowel Syndrome (IBS) Sales Growth Rate (2015-2026)
1.4.2 Global Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2015-2026)
1.4.3 Global Irritable Bowel Syndrome (IBS) Price Trends (2015-2026)
2 Irritable Bowel Syndrome (IBS) Estimate and Forecast by Region
2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Irritable Bowel Syndrome (IBS) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2015-2020)
2.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2015-2020)
2.3 Global Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Irritable Bowel Syndrome (IBS) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Irritable Bowel Syndrome (IBS) Estimates and Projections (2015-2026)
2.4.2 Europe Irritable Bowel Syndrome (IBS) Estimates and Projections (2015-2026)
2.4.3 China Irritable Bowel Syndrome (IBS) Estimates and Projections (2015-2026)
2.4.4 Japan Irritable Bowel Syndrome (IBS) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Irritable Bowel Syndrome (IBS) Estimates and Projections (2015-2026)
2.4.6 India Irritable Bowel Syndrome (IBS) Estimates and Projections (2015-2026)
3 Global Irritable Bowel Syndrome (IBS) Competition Landscape by Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Sales (2015-2020)
3.2 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2015-2020)
3.3 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2019)
3.4 Global Irritable Bowel Syndrome (IBS) Average Price by Company (2015-2020)
3.5 Manufacturers Irritable Bowel Syndrome (IBS) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Irritable Bowel Syndrome (IBS) Players (Opinion Leaders)
4 Global Irritable Bowel Syndrome (IBS) Market Size by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Review by Type (2015-2020)
4.1.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2015-2020)
4.1.3 Global Irritable Bowel Syndrome (IBS) Price by Type (2015-2020)
4.2 Global Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2021-2026)
4.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Type (2021-2026)
4.2.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Type (2021-2026)
5 Global Irritable Bowel Syndrome (IBS) Market Size by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Review by Application (2015-2020)
5.1.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
5.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2015-2020)
5.1.3 Global Irritable Bowel Syndrome (IBS) Price by Application (2015-2020)
5.2 Global Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2021-2026)
5.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Application (2021-2026)
5.2.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Application (2021-2026)
6 United States Irritable Bowel Syndrome (IBS) Market Facts & Figures
6.1 United States Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
6.2 United States Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
6.3 United States Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
7 Europe Irritable Bowel Syndrome (IBS) Market Facts & Figures
7.1 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
7.2 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
7.3 Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
8 China Irritable Bowel Syndrome (IBS) Market Facts & Figures
8.1 China Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
8.2 China Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
8.3 China Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
9 Japan Irritable Bowel Syndrome (IBS) Market Facts & Figures
9.1 Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Company (3015-3030)
9.2 Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
9.3 Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
10 Southeast Asia Irritable Bowel Syndrome (IBS) Market Facts & Figures
10.1 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
11 India Irritable Bowel Syndrome (IBS) Market Facts & Figures
11.1 India Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
11.2 India Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
11.3 India Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Irritable Bowel Syndrome (IBS) Business
12.1 Bausch Health
12.1.1 Bausch Health Corporation Information
12.1.2 Bausch Health Business Overview
12.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Products Offered
12.1.5 Bausch Health Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Allergan Irritable Bowel Syndrome (IBS) Products Offered
12.2.5 Allergan Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Takeda Irritable Bowel Syndrome (IBS) Products Offered
12.3.5 Takeda Recent Development
12.4 Sucampo Pharmaceuticals (Mallinckrodt)
12.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information
12.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
12.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Products Offered
12.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
12.5 Sebela Pharmaceuticals Inc
12.5.1 Sebela Pharmaceuticals Inc Corporation Information
12.5.2 Sebela Pharmaceuticals Inc Business Overview
12.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Products Offered
12.5.5 Sebela Pharmaceuticals Inc Recent Development
12.6 Astellas Pharmaceuticals
12.6.1 Astellas Pharmaceuticals Corporation Information
12.6.2 Astellas Pharmaceuticals Business Overview
12.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Products Offered
12.6.5 Astellas Pharmaceuticals Recent Development
…
13 Irritable Bowel Syndrome (IBS) Manufacturing Cost Analysis
13.1 Irritable Bowel Syndrome (IBS) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)
13.4 Irritable Bowel Syndrome (IBS) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Irritable Bowel Syndrome (IBS) Distributors List
14.3 Irritable Bowel Syndrome (IBS) Customers
15 Market Dynamics
15.1 Irritable Bowel Syndrome (IBS) Market Trends
15.2 Irritable Bowel Syndrome (IBS) Opportunities and Drivers
15.3 Irritable Bowel Syndrome (IBS) Market Challenges
15.4 Irritable Bowel Syndrome (IBS) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Irritable Bowel Syndrome (IBS) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Region (2015-2020)
Table 5. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2015-2020)
Table 6. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Irritable Bowel Syndrome (IBS) Revenue Share by Region (2015-2020)
Table 8. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) Forecast by Region (2021-2026)
Table 9. Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Irritable Bowel Syndrome (IBS) (Million Units) of Key Companies (2015-2020)
Table 13. Global Irritable Bowel Syndrome (IBS) Sales Share by Company (2015-2020)
Table 14. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Irritable Bowel Syndrome (IBS) Revenue Share by Company (2015-2020)
Table 16. Global Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2019)
Table 17. Global Irritable Bowel Syndrome (IBS) Average Price (USD/K Units) of Key Company (2015-2020)
Table 18. Manufacturers Irritable Bowel Syndrome (IBS) Manufacturing Sites and Area Served
Table 19. Manufacturers Irritable Bowel Syndrome (IBS) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Irritable Bowel Syndrome (IBS) Players
Table 22. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 23. Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2015-2020)
Table 24. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Irritable Bowel Syndrome (IBS) Price (Million Units) by Type (2015-2020)
Table 26. Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2021-2026)
Table 27. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2021-2026)
Table 29. Global Irritable Bowel Syndrome (IBS) Price (Million Units) by Type (2021-2026)
Table 30. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2015-2020)
Table 31. Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2015-2020)
Table 32. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Irritable Bowel Syndrome (IBS) Price (Million Units) by Application (2015-2020)
Table 34. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2021-2026)
Table 35. Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2021-2026)
Table 36. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2021-2026)
Table 38. Global Irritable Bowel Syndrome (IBS) Price (Million Units) by Application (2021-2026)
Table 39. United States Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2015-2020)
Table 40. United States Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
Table 41. United States Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 42. United States Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 43. United States Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2015-2020)
Table 44. United States Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
Table 45. Europe Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2015-2020)
Table 46. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
Table 47. Europe Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 48. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 49. Europe Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2015-2020)
Table 50. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 51. China Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2015-2020)
Table 52. China Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
Table 53. China Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 54. China Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 55. China Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2015-2020)
Table 56. China Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
Table 57. Japan Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2015-2020)
Table 58. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
Table 59. Japan Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 60. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 61. Japan Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2015-2020)
Table 62. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2015-2020)
Table 64. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 66. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 68. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
Table 69. India Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2015-2020)
Table 70. India Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2015-2020)
Table 71. India Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2015-2020)
Table 72. India Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2015-2020)
Table 73. India Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2015-2020)
Table 74. India Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2015-2020)
Table 75. Bausch Health Corporation Information
Table 76. Bausch Health Description and Business Overview
Table 77. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 78. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 79. Bausch Health Recent Development
Table 80. Allergan Corporation Information
Table 81. Allergan Description and Business Overview
Table 82. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 83. Allergan Irritable Bowel Syndrome (IBS) Product
Table 84. Allergan Recent Development
Table 85. Takeda Corporation Information
Table 86. Takeda Description and Business Overview
Table 87. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 88. Takeda Irritable Bowel Syndrome (IBS) Product
Table 89. Takeda Recent Development
Table 90. Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information
Table 91. Sucampo Pharmaceuticals (Mallinckrodt) Description and Business Overview
Table 92. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 93. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 94. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 95. Sebela Pharmaceuticals Inc Corporation Information
Table 96. Sebela Pharmaceuticals Inc Description and Business Overview
Table 97. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 98. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 99. Sebela Pharmaceuticals Inc Recent Development
Table 100. Astellas Pharmaceuticals Corporation Information
Table 101. Astellas Pharmaceuticals Description and Business Overview
Table 102. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2015-2020)
Table 103. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 104. Astellas Pharmaceuticals Recent Development
Table 105. Production Base and Market Concentration Rate of Raw Material
Table 106. Key Suppliers of Raw Materials
Table 107. Irritable Bowel Syndrome (IBS) Distributors List
Table 108. Irritable Bowel Syndrome (IBS) Customers List
Table 109. Irritable Bowel Syndrome (IBS) Market Key Trends
Table 110. Irritable Bowel Syndrome (IBS) Key Opportunities and Drivers
Table 111. Irritable Bowel Syndrome (IBS) Market Challenges
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Product Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Irritable Bowel Syndrome (IBS) Market Share by Application in 2020 & 2026
Figure 6. Women Examples
Figure 7. Men Examples
Figure 8. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) Growth Rate (2015-2026)
Figure 9. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Irritable Bowel Syndrome (IBS) Price Trends Growth Rate (2015-2026) (USD/K Units)
Figure 11. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Irritable Bowel Syndrome (IBS) Sales (Million Units) Growth Rate (2015-2026)
Figure 15. Europe Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Irritable Bowel Syndrome (IBS) Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in Irritable Bowel Syndrome (IBS) 2015 & 2019
Figure 26. Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2015-2020)
Figure 28. Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2015-2020)
Figure 30. Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 32. United States Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 33. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2019
Figure 34. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 35. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2019
Figure 36. China Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2019
Figure 37. China Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 38. China Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2019
Figure 39. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2019
Figure 40. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 41. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2019
Figure 42. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2019
Figure 43. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 44. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2019
Figure 45. India Irritable Bowel Syndrome (IBS) Sales Market Share by Company in 2019
Figure 46. India Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2019
Figure 47. India Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Irritable Bowel Syndrome (IBS)
Figure 50. Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)
Figure 51. Irritable Bowel Syndrome (IBS) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
下痢同伴過敏性腸症候群（IBS-D）治療薬の世界市場レポート2020 Rifaximin (Xifaxan) is an antibiotic medication for IBS-D that works by reducing or altering gut bacteria, and it can improve symptoms of bloating and diarrhea after a 10 to 14 day course of treatment. Some patients require retreatment at higher doses for symptom relief. Market Analysis and Insights…- 便秘薬による過敏性腸症候群の世界市場レポート2020 The symptoms of IBS-C include abdominal pain and discomfort, along with changes in bowel function. Bloating and/or gas also may happen. Changes in bowel function may include straining, infrequent stools, hard or lumpy stools, and/or a feeling that the bowel does not empty completely. Market Analysis…
- 豚生殖・呼吸器症候群ワクチンの世界市場レポート2020 Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Boehringer ingelheim is the company with the largest market share, about 25 percent. Market Analysis and Insights: Global S…
- プロバイオティクスサプリメントの世界市場レポート2020 Market Analysis and Insights: Global Probiotics Suppliment Market The global Probiotics Suppliment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Probiotics Suppliment Scope and Market Size The global Probiotics Suppli…
- 眼科薬の世界市場レポート2020 Market Analysis and Insights: Global Ophthalmol Drug Market The global Ophthalmol Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Ophthalmol Drug Scope and Market Size The global Ophthalmol Drug market is segmented…